menu search

Nuvalent to present preliminary phase 1 data from arros-1 clinical trial of nvl-520 at 34th eortc-nci-aacr symposium and announces pipeline updates

Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Precli...

September 7, 2022, 6:30 am

Should you short target (tgt) stock now?

Source: jejim / Shutterstock.com Independent investment research publication Hedgeye recently targeted Target (NYSE: TGT ) stock as a potential short ...

September 6, 2022, 5:08 pm

Crispr therapeutics' (crsp) pipeline development fuels growth

While CRISPR Therapeutics' (CRSP) lead candidate is still a couple of years away from commercialization...

September 6, 2022, 12:02 pm

Immuneering (imrx) files ind for cancer candidate imm-1-104

Immuneering (IMRX) files an investigational new drug (IND) application to the FDA to start a phase I/IIa study on IMM-1-104 for the treatment of advan...

September 5, 2022, 12:02 pm

Axsome (axsm) starts late-stage study of migraine drug axs-07

Axsome (AXSM) initiates a phase III open-label study for its pipeline candidate, AXS-07 for treating ac...

September 2, 2022, 2:17 pm

Pliant (plrx) receives positive review of ipf study at top dose

Pliant (PLRX) receives a positive DSMB review of the ongoing mid-stage study evaluating the company's lead can...

September 2, 2022, 1:32 pm

Exclusive-shell's ceo van beurden prepares to step down next year -sources

Shell has shortlisted four candidates to succeed Chief Executive Ben van Beurden who is preparing to st...

September 2, 2022, 2:06 am

Harpoon therapeutics: a well undervalued tri-specific oncology player

Harpoon Therapeutics is an oncology platform play developing tri-specific drug candidates. The company'...

September 1, 2022, 5:17 am

Should investors buy bp stock?

When considering companies that will contribute to a strong portfolio, the oil and energy sector offers many c...

August 29, 2022, 9:03 pm

Swiss regulator grants temporary authorization for moderna bivalent covid booster for adults age 18 and older

Moderna Inc. MRNA, -3.77% said Monday the Swiss regulator has granted temporary authorization to its bivalent omicron-targeting COVID booster for use ...

August 29, 2022, 6:25 am

Erytech (eryp) stops developing drug in leukemia, down 19.6%

After evaluating the FDA's feedback, Erytech Pharma (ERYP) halts developing its lead candidate in leuke...

August 26, 2022, 3:03 pm

Kodiak sciences (kod) rises 60% in past 3 months: here's why

Kodiak Sciences (KOD) has progressed well with the development of its lead pipeline candidate, tarcocim...

August 26, 2022, 3:03 pm

Pfizer announces positive data from phase 3 trial of older adults for bivalent rsv vaccine candidate

Pfizer Inc. PFE, -1.21% said Thursday a Phase 3 trial of older adults testing its bivalent RSV vaccine candid<...

August 25, 2022, 7:42 am

Immuneering announces participation in september investor conferences

CAMBRIDGE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinforma...

August 25, 2022, 6:50 am

Circling back on precigen

Today, we circle back on Precigen, a biotech firm that was once part of Intrexon. Precigen is advancing several drug ...

August 23, 2022, 5:24 pm

Bluebird (blue) up 101% in the past three months: here's why

bluebird bio (BLUE) has surged in the past three months owing to its pipeline development. The company's lead ...

August 23, 2022, 2:17 pm

Instagram's latest feature test is about being bereal

The unwritten rule of the internet is that “if there's a new social media feature, Instagram will copy it.” In the latest example, the Meta-owned ...

August 23, 2022, 7:59 am

Vyant bio posts q2 results, set to advance vynt-0126 to treat rett syndrome into clinical trials early next year

Vyant Bio (NASDAQ:VYNT) Inc revealed that it is advancing its repurposed drug candidate, VYNT-0126 to t...

August 23, 2022, 7:07 am

Cardiff oncology: down but not out

Today, we circle back on small developmental concern Cardiff Oncology for the first time since the fourth quarter of 2021. The company's primary drug ...

August 22, 2022, 7:03 pm

Ralph nader asks nhtsa to recall tesla's ‘dangerous and irresponsible' fsd

Ralph Nader, a political and consumer advocate and former presidential candidate, has issued a statemen...

August 10, 2022, 6:17 pm


Search within

Pages Search Results: